Results 211 to 220 of about 155,675 (375)

Advancements in left ventricular assist devices to prevent pump thrombosis and blood coagulopathy

Journal of Anatomy, Volume 242, Issue 1, Page 29-49, January 2023., 2023
Left ventricular assist device (LVAD)‐related blood coagulopathy: Pump thrombosis is one of the most severe adverse events caused by LVADs. The contact of blood with artificial materials of LVAD pumps and cannulas triggers the coagulation cascade. Abstract Mechanical circulatory support (MCS) devices, such as left ventricular assist devices (LVADs) are
Grainne Malone, Gerges Abdelsayed, Fianait Bligh, Fatma Al Qattan, Saifullah Syed, Prateepan Varatharajullu, Augustin Msellati, Daniela Mwipatayi, Maimoona Azhar, Andrew Malone, Saulat H. Fatimi, Claire Conway, Aamir Hameed   +12 more
wiley   +1 more source

Case Report: Diagnosis and successful treatment of a rare case of steroid-refractory chronic graft-vs-host disease-related serositis. [PDF]

Front Immunol
Xiong Z, Wang Z, Chen X.
europepmc   +1 more source

Management of Chronic Graft-vs.-Host Disease in Children and Adolescents With ALL: Present Status and Model for a Personalised Management Plan. [PDF]

Front Pediatr, 2022
Sobkowiak-Sobierajska A, Lindemans C, Sykora T, Wachowiak J, Dalle JH, Bonig H, Gennery A, Lawitschka A.   +7 more
europepmc   +1 more source

116Rapid engraftment is associated with an increased incidence of graft vs host disease (GVHD) in children following reduced-intensity hematopoietic stem cell transplantation (RI-HSCT)

, 2003
Lauren B. Bruckner, R. Duerst, Morris Kletzel   +2 more
openalex   +1 more source

Organic management shapes AM fungal community structure and function, partially mitigating the negative effects of conventional agriculture

Functional Ecology, EarlyView.
Read the free Plain Language Summary for this article on the Journal blog. Abstract Arbuscular mycorrhizal (AM) fungi are important plant symbionts that provide plants with nutrients and water as well as support plant defences against pests and disease.
Meike Katharina Heuck, Jeff R. Powell, Jarrod Kath, Christina Birnbaum, Adam Frew   +4 more
wiley   +1 more source

Severe Hypertriglyceridemia in a Patient Treated With Sirolimus for Graft-vs-Host Disease Prophylaxis. [PDF]

JCEM Case Rep
Criner K, Student J, Arkin J, Carp J, Sokoloff S.   +4 more
europepmc   +1 more source

Prognostic Value of Cutaneous Disease Severity Estimates on Survival Outcomes in Patients With Chronic Graft-vs-Host Disease.

JAMA Dermatol, 2023
Baumrin E, Baker LX, Byrne M, Martin PJ, Flowers ME, Onstad L, El Jurdi N, Chen H, Beeghly-Fadiel A, Lee SJ, Tkaczyk ER.   +10 more
europepmc   +1 more source

Long-term transplant outcomes after allogeneic hematopoietic transplant in pediatric patients with hematological malignancies are influenced by severe chronic graft vs. host disease and immune reconstitution. [PDF]

Front Pediatr, 2022
Molina B, González-Vicent M, Lopez I, Pereto A, Ruiz J, Ramirez M, Díaz MA.   +6 more
europepmc   +1 more source

Overlapping immune responses in donor lymphocyte infusion (DLI)-associated graft-vs-host disease

, 2004
Allan D. Hess, Yuji Miura, Emilie C. Bright, Christopher Thoburn, Georgia B. Vogelsang   +4 more
openalex   +1 more source

Upregulation of plasma CCL8 in mouse model of graft-vs-host disease [PDF]

, 2009
Akinobu Ota, Masaki Yamamoto, Tsukasa Hori, Shunsuke Miyai, Yasuyoshi Naishiro, Hitoshi Sohma, Masahiro Maeda, Yasuo Kokai   +7 more
openalex   +1 more source